Efficacy and safety of concomitant left atrial appendage clipping during heart valve surgery: a report of 58 cases.
10.3724/zdxbyxb-2024-0636
- Author:
Zheng XU
1
;
Haiyan XIANG
2
;
Jiwei WANG
3
;
Chen LIU
3
;
Yanhua TANG
2
;
Juesheng YANG
4
,
5
Author Information
1. Department of Cardiovascular Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang 330008, China. 385819887@qq.com.
2. Department of Cardiovascular Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang 330008, China.
3. Department of Ultrasonography, the Second Affiliated Hospital of Nanchang University, Nanchang 330008, China.
4. Department of Cardiovascular Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang 330008, China. mniyjs162000@
5. com.
- Publication Type:Journal Article
- Keywords:
Atrial fibrillation;
Efficacy;
Left atrial appendage clipping;
Mid-term follow-up;
Retrospective study;
Safety;
Valvular heart diseases
- MeSH:
Humans;
Atrial Appendage/surgery*;
Atrial Fibrillation/complications*;
Male;
Female;
Heart Valve Diseases/complications*;
Aged;
Middle Aged;
Heart Valve Prosthesis Implantation/methods*;
Treatment Outcome;
Cardiac Surgical Procedures/methods*;
Mitral Valve/surgery*
- From:
Journal of Zhejiang University. Medical sciences
2025;54(2):250-256
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:To analyze the efficacy and safety of concomitant left atrial appendage clipping during heart valve surgery for valvular heart disease patients with atrial fibrillation.
METHODS:Fifty-eight patients who underwent concomitant left atrial appendage clipping during cardiac valve surgery in the Second Affiliated Hospital of Nanchang University from January 2017 to June 2023 were included in the analysis, including 1 case who underwent aortic valve replacement, 49 cases who underwent mitral valve replace-ment (or valvuloplasty)+tricuspid valvuloplasty, and 8 cases who underwent double valve replacement+tricuspid valvuloplasty (3 cases combined with coronary artery bypass grafting). The patients were followed up for 3-36 months [(16.69±6.61) months] after operation, and the changes of cardiac function and the occurrence of serious adverse complications were evaluated.
RESULTS:The cardiopulmonary bypass time ranged from 75 to 145 min [(102.50±21.03) min], and the aortic cross-clamp time ranged from 35 to 80 min [(58.02±14.63) min]. The length of postoperative intensive care unit stay was 1 to 5 days [(2.47±0.82) d], and the length of postoperative hospital stay was 7 to 22 days [(10.84±2.69) d]. Cardiac ultrasound indicated complete closure of the left atrial appendage in all cases. During the follow-up, New York Heart Association (NYHA) functional classifications were improved in 54 patients. No left atrial appendage-related bleeding events or other perioperative complications were observed; and no cerebral infarction, limb embolism events, or mortality cases occurred during the follow-up.
CONCLUSIONS:For valvular heart disease patients with atrial fibrillation, concomitant left atrial appendage clipping during cardiac valve surgery demonstrates efficacy and safety, with no severe adverse events during a medium-term follow-up.
